Related Experiment Video
Updated: Mar 12, 2026
04:01
Author Spotlight: Tracing the Ferroptotic Signatures and Cell Death Dynamics in Medulloblastoma for Advanced Therapeutics
Published on: March 15, 2024
2.1K
ACSL4 dictates ferroptosis sensitivity by shaping cellular lipid composition
Sebastian Doll1, Bettina Proneth1, Yulia Y Tyurina2
1Institute of Developmental Genetics, Helmholtz Zentrum München, Neuherberg, Germany.
Nature Chemical Biology
|November 15, 2016
Summary
Researchers identified acyl-CoA synthetase long-chain family member 4 (ACSF4) as crucial for ferroptosis, a cell death process. Inhibiting ACSL4 offers a potential therapeutic strategy for ferroptosis-related diseases.
Area of Science:
- Cell Death Mechanisms
- Biochemistry
- Cancer Biology
Background:
- Ferroptosis is a regulated necrotic cell death pathway.
- Glutathione peroxidase 4 (GPX4) controls ferroptosis.
- Understanding ferroptosis regulation is crucial for therapeutic development.
Purpose of the Study:
- To identify key regulators of ferroptosis.
- To uncover mechanisms predicting ferroptosis sensitivity or resistance.
- To explore therapeutic targets for ferroptosis modulation.
Main Methods:
- Genome-wide CRISPR-based genetic screening.
- Microarray analysis of ferroptosis-resistant cell lines.
- Investigating the role of acyl-CoA synthetase long-chain family member 4 (ACSL4) in ferroptosis.
Main Results:
- ACSL4 was identified as essential for ferroptosis execution.
- Gpx4-Acsl4 double-knockout cells exhibited significant ferroptosis resistance.
- ACSL4 enriches cell membranes with polyunsaturated ω6 fatty acids.
- ACSL4 expression predicted ferroptosis sensitivity in basal-like breast cancer cells.
Conclusions:
- ACSL4 is a critical mediator of ferroptosis.
- Targeting ACSL4 with compounds like thiazolidinediones can prevent ferroptosis.
- ACSL4 inhibition represents a potential therapeutic strategy for ferroptosis-related diseases.
